It has long been known that nitrate and nitrite medications consistently ca
use significant headache as a side effect. Classical research has shown tha
t cerebral vasodilation accompanies the use of these medications. Merit mod
ern studies suggest that these vasodilators exert their action on blood ves
sels via nitric oxide and its second messenger, cyclic guanosine monophosph
ate. This paper reviews research studies and theoretical articles which add
ress the concept that nitric oxide plays a major role in the vasodilation a
ssociated with the headache phase of migraine with aura. A brief discussion
of nitric oxide biochemistry and pharmacology follows.
In addition, there is a review of evidence examining the possible contribut
ions of nitric oxide to the neurogenic and vascular events associated with
spreading cortical depression, an animal model of migraine aura. The parado
xical hypotheses that nitric oxide may contribute to both the propagation o
f spreading cortical depression and its limitation are presented. Finally,
a rationale for the experimental use of nitric oxide agonists and antagonis
ts in the abortion of migraine aura is introduced.